Bill > H945

This bill aims to ensure prescription drug cost transparency and affordability. Key provisions: 1. Defines important terms like "brand name drug," "generic drug," "pharmacy benefit manager," and "wholesale acquisition cost." 2. Requires the Health Policy Commission to keep certain information confidential and allows the Attorney General to access and analyze this information. 3. Gives the Health Policy Commission authority to review prescription drug pricing and make recommendations to reduce costs. 4. Requires pharmacy benefit managers to be licensed and audited by carriers they contract with, and prohibits certain practices that could lead to conflicts of interest. 5. Includes provisions to increase reporting and data collection on prescription drug utilization, spending, and pricing trends to enhance transparency. Overall, the bill seeks to improve oversight, accountability, and affordability in the prescription drug market by expanding the authority and information available to state agencies and regulators.

Business and Industry, Health and Social Services

https://malegislature.gov/Bills/193/H945